Balanced news tone
News Sentiment
VTRS sentiment intelligence
Viatris Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
53 relevant articles
News tone and price action are not far from neutral.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-2.6% over one week, -1.3% over four weeks, trend active, and materially above fair value.
Viatris Inc. stock rises Wednesday, outperforms market
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
77/100 classification
One-week reaction
-2.6%
Price reacting lower
Trend fit
Trend active
-1.3% over four weeks
Fair value
51.2%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
20
Neutral
28
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Market source
Direct company coverage
Viatris (VTRS) Stock And The 58% Undervaluation Debate After A Strong Year Of Returns
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
FDA Accepts Viatris' NDA for Fast-Acting Non-Opioid Pain Therapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
New non-opioid pain drug from Viatris faces FDA decision on Dec. 27, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Stock Titan
Morningstar
Direct company coverage
After Kicking Off 2026 Solidly, Viatris Looks to New Launches and Cost Savings for Long-term Growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Morningstar
Market source
Direct company coverage
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Viatris (VTRS) Heavy FY 2025 Losses Keep Bullish Turnaround Narratives Under Pressure
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- simplywall.st
PR Newswire
Direct company coverage
Viatris Reports First-Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- PR Newswire
Market source
Direct company coverage
Assessing Viatris (VTRS) Valuation After Its Recent Share Price Rebound
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Are Wall Street Analysts Bullish on Viatris Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Davis Selected Advisers (NASDAQ: VTRS) reports 78.21M shares, 6.8% stake
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 05 May 2026 07:00
- Source
- Stock Titan
Market source
Direct company coverage
Is It Too Late To Consider Viatris (VTRS) After Its Strong One Year Share Price Run
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
Viatris Contraceptive Patch Data Puts Women’s Health Growth Story In Focus
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is Viatris (VTRS) One of the Best Medical Stocks to Buy Under $30?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Vanguard discloses 7.36% stake in Viatris (NASDAQ: VTRS)
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 30 Apr 2026 07:00
- Source
- Stock Titan
Fierce Pharma
Direct company coverage
Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 16 Apr 2026 07:00
- Source
- Fierce Pharma
PR Newswire
Direct company coverage
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 19 Mar 2026 07:00
- Source
- PR Newswire
Market source
Direct company coverage
What Are Analysts Saying About Viatris Inc (VTRS) Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Mar 2026 07:00
- Source
- Market source
PR Newswire
Direct company coverage
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 26 Feb 2026 08:00
- Source
- PR Newswire
Market source
Direct company coverage
Where is Viatris Inc. (VTRS) Headed According to the Street?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- Market source
Market source
Direct company coverage
Why Viatris (VTRS) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Feb 2026 08:00
- Source
- Market source
Viatris Newsroom
Direct company coverage
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 Nov 2025 08:00
- Source
- Viatris Newsroom